Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).

by Alexander N Shakhov, Vijay K Singh, Frederick Bone, Alec Cheney, Yevgeniy Kononov, Peter Krasnov, Troitza K Bratanova-Toshkova, Vera V Shakhova, Jason Young, Michael M Weil, Angela Panoskaltsis-Mortari, Christie M Orschell, Patricia S Baker, Andrei Gudkov, Elena Feinstein
Published 2012-01-01

Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes

by Tracy Gasperetti, Tessa Miller, Feng Gao, Jayashree Narayanan, Elizabeth R. Jacobs, Elizabeth R. Jacobs, Elizabeth R. Jacobs, Elizabeth R. Jacobs, Aniko Szabo, George N. Cox, Christie M. Orschell, Brian L. Fish, Meetha Medhora, Meetha Medhora, Meetha Medhora, Meetha Medhora, Meetha Medhora
Published 2021-05-01

Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes

by Tracy Gasperetti, Tessa Miller, Feng Gao, Jayashree Narayanan, Elizabeth R. Jacobs, Elizabeth R. Jacobs, Elizabeth R. Jacobs, Elizabeth R. Jacobs, Aniko Szabo, George N. Cox, Christie M. Orschell, Brian L. Fish, Meetha Medhora, Meetha Medhora, Meetha Medhora, Meetha Medhora, Meetha Medhora
Published 2021-08-01